Kaifan Bao
Biographic Data
| ID | 7273813 |
|---|---|
| NAME | Kaifan Bao |
| GIVEN NAMES | Kaifan |
| FAMILY NAME | Bao |
| SIGNATURE | BAO K |
| AFFILIATIONS | Nanjing University of Chinese Medicine |
| ORCID | 0000-0001-7344-9368 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Cimifugin relieves the relapse of allergic asthma via inhibiting ILC2 migration by targeting CCR9
Direct targeting of STAT3 by xanthatin suppresses allergic airway inflammation via inhibition of TSLP release and NK2 cell polarization
Xanthatin ameliorates allergic airway inflammation by directly targeting STAT3, thereby dually inhibiting the TSLP/STAT3 axis in epithelial cells and the subsequent STAT3-dependent differentiation of pathogenic NK2 cells, presenting a promising multi-targeted strategy for asthma treatment
Formononetin attenuates atopic dermatitis by upregulating A20 expression via activation of G protein-coupled estrogen receptor
No prominent works on this page.
Formononetin attenuates atopic dermatitis by upregulating A20 expression via activation of G protein-coupled estrogen receptor
Cimifugin relieves the relapse of allergic asthma via inhibiting ILC2 migration by targeting CCR9
Direct targeting of STAT3 by xanthatin suppresses allergic airway inflammation via inhibition of TSLP release and NK2 cell polarization
Xanthatin ameliorates allergic airway inflammation by directly targeting STAT3, thereby dually inhibiting the TSLP/STAT3 axis in epithelial cells and the subsequent STAT3-dependent differentiation of pathogenic NK2 cells, presenting a promising multi-targeted strategy for asthma treatment
Allergic asthma (2 works) · Asthma (2 works) · Inflammation (2 works) · Airway (1 work) · Allergic inflammation (1 work) · Allergic Rhinitis and Sensitization (1 work) · Allergy (1 work) · Asthma and respiratory diseases (1 work) · Asthma exacerbations (1 work) · Biochemistry (1 work)